Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Patients' understanding of and responses to multiplex genetic susceptibility test results.

Kaphingst KA, McBride CM, Wade C, Alford SH, Reid R, Larson E, Baxevanis AD, Brody LC.

Genet Med. 2012 Jul;14(7):681-7.

2.

Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.

Cassidy MR, Roberts JS, Bird TD, Steinbart EJ, Cupples LA, Chen CA, Linnenbringer E, Green RC.

Alzheimers Dement. 2008 Nov;4(6):406-13. doi: 10.1016/j.jalz.2008.04.007.

3.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
4.

Differences in BRCA counseling and testing practices based on ordering provider type.

Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro AN, Vadaparampil ST, Sellers TA, Pal T.

Genet Med. 2015 Jan;17(1):51-7. doi: 10.1038/gim.2014.75. Epub 2014 Jun 12.

5.

Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.

McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC.

Genet Med. 2009 Aug;11(8):582-7. doi: 10.1097/GIM.0b013e3181b22c3a.

6.

Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.

McGrath SP, Coleman J, Najjar L, Fruhling A, Bastola DR.

Public Health Genomics. 2016;19(2):116-24. doi: 10.1159/000444477. Epub 2016 Mar 8.

PMID:
26950077
7.

Parents' attitudes toward pediatric genetic testing for common disease risk.

Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, McBride CM.

Pediatrics. 2011 May;127(5):e1288-95. doi: 10.1542/peds.2010-0938. Epub 2011 Apr 18.

8.

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.

Pediatrics. 2001 Apr;107(4):699-705.

PMID:
11335747
9.

An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.

Green MJ, Biesecker BB, McInerney AM, Mauger D, Fost N.

Am J Med Genet. 2001 Sep 15;103(1):16-23.

PMID:
11562929
10.

Effects of undergoing multiplex genetic susceptibility testing on parent attitudes towards testing their children.

Madeo AC, Tercyak KP, Tarini BA, McBride CM.

Ann Behav Med. 2014 Jun;47(3):388-94. doi: 10.1007/s12160-013-9553-z.

11.

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.

Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):369-75.

12.

Consumers' use of web-based information and their decisions about multiplex genetic susceptibility testing.

Kaphingst KA, McBride CM, Wade C, Alford SH, Brody LC, Baxevanis AD.

J Med Internet Res. 2010 Sep 29;12(3):e41. doi: 10.2196/jmir.1587.

13.

Introducing genetic testing for cardiovascular disease in primary care: a qualitative study.

Middlemass JB, Yazdani MF, Kai J, Standen PJ, Qureshi N.

Br J Gen Pract. 2014 May;64(622):e282-9. doi: 10.3399/bjgp14X679714.

14.

Association between health-service use and multiplex genetic testing.

Reid RJ, McBride CM, Alford SH, Price C, Baxevanis AD, Brody LC, Larson EB.

Genet Med. 2012 Oct;14(10):852-9. doi: 10.1038/gim.2012.52. Epub 2012 May 17.

15.

Primary care providers' willingness to recommend BRCA1/2 testing to adolescents.

O'Neill SC, Peshkin BN, Luta G, Abraham A, Walker LR, Tercyak KP.

Fam Cancer. 2010 Mar;9(1):43-50. doi: 10.1007/s10689-009-9243-y. Epub 2009 Apr 24.

16.

Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs.

Hock KT, Christensen KD, Yashar BM, Roberts JS, Gollust SE, Uhlmann WR.

Genet Med. 2011 Apr;13(4):325-32. doi: 10.1097/GIM.0b013e3182011636.

17.

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS.

BMC Health Serv Res. 2012 Jan 18;12:16. doi: 10.1186/1472-6963-12-16.

18.

Public interest in predictive genetic testing, including direct-to-consumer testing, for susceptibility to major depression: preliminary findings.

Wilde A, Meiser B, Mitchell PB, Schofield PR.

Eur J Hum Genet. 2010 Jan;18(1):47-51. doi: 10.1038/ejhg.2009.138.

19.

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1579-85.

20.

Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Haga SB, Mills R, Bosworth H.

Patient Educ Couns. 2014 Oct;97(1):10-5. doi: 10.1016/j.pec.2014.06.007. Epub 2014 Jun 21. Review.

Supplemental Content

Support Center